RNA Therapeutics News

This is selected news for RNA Therapeutics, which is filed under Healthcare Topics. There are 15 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/20/2022 Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead™ Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference
... GMT on Thursday, September 22, 2022 Presentation Topics : For more information about Sirnaomics' presentation, please visit the event website at https://www.smgconferences.com/pharmaceuticals/uk/conference/oligonucleotide-discovery-delivery . About Sirnaomics Sirnaomics is an RNA therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery ...
Yahoo News
9/20/2022 Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead™ Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference
... GMT on Thursday, September 22, 2022 Presentation Topics : For more information about Sirnaomics' presentation, please visit the event website at https://www.smgconferences.com/pharmaceuticals/uk/conference/oligonucleotide-discovery-delivery . About Sirnaomics Sirnaomics is an RNA therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery ...
Yahoo News
9/20/2022 2nd Mrna Analytical Development Summit
... Gallery Gallery Event Team Phone: +16174554188 E-mail: Filed in: Things to do near Boston, MA » Conferences » Science Welcome to the 2nd mRNA Analytical Development Summit: Trailblazing Advanced Analytics for Superior mRNA Therapeutics and Vaccines Uniting 80+ Senior Scientists, Directors, and Heads of Analytical Development, Quality Control, CMC ...
eventsnearhere.com
9/20/2022 Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead™ Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference
... at Copthorne Tara Hotel, London, UK. Presentation Details For more information about Sirnaomics' presentation, please visit the event website at https://www.smgconferences.com/pharmaceuticals/uk/conference/oligonucleotide-discovery-delivery . About Sirnaomics Sirnaomics is an RNA therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery ...
prnasia.com
9/15/2022 Small non-coding RNA therapeutics for cardiovascular disease
... holder in Purespring Therapeutics, Forcefield Therapeutics, and Heqet Therapeutics, and is a member of the Scientific Advisory Boards of Trizell Holding SA and DINAQR AG. Ajay M Shah, Mauro Giacca, Small non-coding RNA therapeutics for cardiovascular disease, European Heart Journal, 2022;, ehac463, https://doi.org/10.1093/eurheartj/ehac463 Novel bio ...
oup.com
9/12/2022 OncXerna Therapeutics Announces New Xerna‚Ñ¢ TME Panel Biomarker Data from Retrospective Analysis of Results from a Randomized Phase 2 Trial Evaluating Anti-PD-1 Maintenance Therapy in Esophagogastric Adenocarcinoma at the ESMO Congress 2022 Globe Newswire
9/12/2022 OncXerna Therapeutics Announces New Xerna‚Ñ¢ TME Panel Biomarker Data from Retrospective Analysis of Results from a Randomized Phase 2 Trial Evaluating Anti-PD-1 Maintenance Therapy in Esophagogastric Adenocarcinoma at the ESMO Congress 2022 Yahoo News
9/12/2022 OncXerna Therapeutics Announces New Xerna‚Ñ¢ TME Panel Biomarker Data from Retrospective Analysis of Results from a Randomized Phase 2 Trial Evaluating Anti-PD-1 Maintenance Therapy in Esophagogastric Adenocarcinoma at the ESMO Congress 2022 - Law News Today - EIN Presswire einnews.com
9/9/2022 RNA therapeutics heart failure by Gatehouse Bio and AstraZeneca pharmaceutical-technology.com
9/8/2022 OncXerna Therapeutics Doses First Patient in Phase 2 Trial Globe Newswire
9/8/2022 OncXerna Therapeutics Doses First Patient in Phase 2 Trial Evaluating Navicixizumab Alone or in Combination with Chemotherapy in Patients with Select Advanced Solid Tumors Yahoo News
9/8/2022 Gatehouse Bio Extends Its Partnership with AstraZeneca to Develop RNA Therapeutics for Heart Failure | Business Wire Business Wire
9/7/2022 Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development PR Newswire
9/7/2022 Emerging Non-coding Rna Therapeutics Summit (virtual Event) eventsnearhere.com
8/25/2022 CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer fiorreports.com
8/17/2022 Merck partners with Orna Therapeutics to develop Orna's RNA technology ns-healthcare.com
8/16/2022 Sirnaomics Develops Peptide Docking Vehicle (PDoV™) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics | BioSpace BioSpace
8/16/2022 Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic PR Newswire
8/16/2022 Merck and Orna Therapeutics Collaborate to Advance Orna's Next Generation of RNA Technology | Business Wire Business Wire
8/16/2022 Sirnaomics Develops Peptide Docking Vehicle (PDoV™) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics PR Newswire
8/16/2022 Merck and Orna Therapeutics Collaborate to Advance Orna's Next Generation of RNA Technology Yahoo News
8/16/2022 Merck and Orna Therapeutics Collaborate to Advance Orna's Next Generation of RNA Technology | Insider Tracking insidertracking.com
8/16/2022 Merck and Orna Therapeutics Collaborate to Advance Orna's Next Generation of RNA Technology acrofan.com
8/16/2022 Merck and Orna Therapeutics Collaborate to Advance Orna's Next Generation of RNA Technology - Stocks of the Day stocksoftheday.com
8/16/2022 Merck and Orna Therapeutics Collaborate to Advance Orna's Next Generation of RNA Technology | BioSpace BioSpace